Relative Strength Chart Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:00 2026-09-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 3.130 USD | +0.32% |
|
+0.64% | +13.82% |
| Aug. 19 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| Aug. 14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +0.32% | +0.64% | +13.82% | -9.54% | -54.41% | 357M |  |  |  |
- Stock Market
- Stocks
- CATX Stock
- Charts Perspective Therapeutics, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
